51 completed. 51 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 51 | Completed 51 |
Follow Myelitis: new trials by email Literature Review of Myelitis trials Research Report on Myelitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Booster Dose of sIPV Co-administered With MMR and HepA-I. sIPV, MMR, HepA-I - Poliomyelitis | Phase 4 | Completed | Sinovac Biotech Co., Ltd | 889 | 2024-08-08 | 2026-01-16 |
| Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different Manufacturers sIPV - Poliomyelitis | Phase 4 | Completed | Sinovac Biotech Co., Ltd | 200 | 2024-05-20 | 2025-03-14 |
| A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2 nOPV2 - Poliomyelitis | Phase 4 | Completed | Fidec Corporation | 501 | 2023-11-09 | 2026-09-03 |
| Assessing Immunogenicity of Intramuscular Sabin Inactivated Poliovirus Vaccine and Non-inferiority of Intradermal Fractional Inactivated Poliovirus Vaccine Full dose Sabin Inactivated Poliovirus Vaccine produced by IMBCAMS, Fractional (1/5) Dose Sabin Inactivated Poliovirus Vaccine produced by IMBCAMS, Full dose Sabin Inactivated Poliovirus Vaccine produced by BIBP - Poliomyelitis | Phase 4 | Completed | Centers for Disease Control and Prevention | 1224 | 2022-07-26 | 2025-03-19 |
| A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants sIPV vaccine /DTaP vaccine, sIPV vaccine /Hepatitis A inactivated vaccine /MMR vaccine - Poliomyelitis | Phase 4 | Completed | Sinovac Biotech Co., Ltd | 3200 | 2022-06-13 | 2023-01-12 |
| Evaluation of Persistence of Immunity in 4-year-old Children Previously Immunised With IPV-Al AJV (Picovax®) IPV-Al - Poliomyelitis | Phase 4 | Completed | AJ Vaccines A/S | 163 | 2020-11-20 | 2021-06-22 |
| Immunogenicity and Safety of the Booster Dose of Polio Vaccine With Different Primary Sequential Schedules in China vaccinated with Sabin IPV, vaccinated with bOPV - Polio, Vaccine Reaction | Phase 4 | Completed | Zhejiang Provincial Center for Disease Control and Prevention | 387 | 2020-11-05 | 2022-03-07 |
| Monovalent Oral Poliovirus Vaccine Type 1 Intestinal and Humoral Immunity Study mOPV1, bOPV, fIPV - Poliomyelitis | Phase 4 | Completed | Centers for Disease Control and Prevention | 1256 | 2018-12-18 | 2021-02-21 |
| Persistence of IPV Immunity Inactivated Polio Vaccine (IPV) - Poliomyelitis | Phase 4 | Completed | Tribhuvan University Teaching Hospital, Institute Of Medicine. | 502 | 2018-11-21 | 2020-04-07 |
| A Study of Immunogenicity and Seroconversion With Sabin IPV Schedules in China. Sabin IPV - Poliomyelitis | Phase 4 | Completed | Centers for Disease Control and Prevention, China | 560 | 2018-05-28 | 2020-06-24 |
| Sero-conversion Study for a Two-dose Schedule of Sabin IPV in China Sabin IPV - Poliomyelitis | Phase 4 | Completed | Centers for Disease Control and Prevention, China | 280 | 2018-05-24 | 2020-06-24 |
| Consistency Study for Three Commercial Lots of Inactivated Poliomyelitis Vaccine Made From Sabin Strain sIPV batch 1, sIPV batch 2, sIPV batch 3 - Poliomyelitis | Phase 4 | Completed | Institute of Medical Biology, Chinese Academy of Medical Sciences | 1200 | 2018-04-15 | 2023-10-11 |
| Inactivated Poliomyelitis Vaccine Made From Sabin Strain Inactivated Poliomyelitis Vaccine Made From Sabin Strain - Poliomyelitis | Phase 4 | Completed | Institute of Medical Biology, Chinese Academy of Medical Sciences | 49731 | 2018-02-08 | 2023-10-11 |
| MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study MP Diagnostics HTLV Blot 2.4 - HTLV-I Infections, HTLV-II Infections | Phase 4 | Completed | MP Biomedicals, LLC | 150 | 2018-01-15 | 2018-09-13 |
| Duration of IPV Priming and Antibody Decay Bivalent oral poliovirus vaccine (bOPV) at 6,10 and 14 weeks of age, Inactivated poliovirus vaccine (IPV) at 14 weeks and 18 months of age, Inactivated poliovirus vaccine (IPV) at 14 weeks, 18 weeks and 18 months of age - Poliomyelitis | Phase 4 | Completed | Centers for Disease Control and Prevention | 1645 | 2017-11-05 | 2020-11-25 |
| Immunogenicity and Safety Evaluation of Different Sequential Immunization Strategies by Sabin IPV and bOPV in Chinese Infants Sabin IPV+ bOPV+ bOPV, Sabin IPV + Sabin IPV + bOPV, Sabin IPV + Sabin IPV + Sabin IPV - Polio | Phase 4 | Completed | Zhejiang Provincial Center for Disease Control and Prevention | 528 | 2017-05-02 | 2019-09-12 |
| Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery Infanrix hexa - Diphtheria, Hepatitis B | Phase 4 | Completed | GlaxoSmithKline | 551 | 2016-09-19 | 2020-01-14 |
| Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study IPV at 14 and 22 weeks of age, Rotarix, IPV at 14 and 22 weeks of age, RotaTeq, IPV at 14 and fIPV at 22 weeks, Rotarix - Poliomyelitis | Phase 4 | Completed | Centers for Disease Control and Prevention | 1144 | 2016-09-01 | 2018-07-18 |
| Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery Infanrix hexa, Prevnar13 - Acellular Pertussis, Tetanus | Phase 4 | Completed | GlaxoSmithKline | 601 | 2016-01-22 | 2019-07-09 |
| Immunogenicity of Monovalent Type 2 Oral Poliovirus Vaccine mOPV2 at 6 and 7 weeks of age, mOPV2 at 6 and 8 weeks of age, mOPV2 at 6 and 10 weeks of age - Poliomyelitis | Phase 4 | Completed | Centers for Disease Control and Prevention | 760 | 2015-12-01 | 2018-01-25 |
Showing 20 of 51. Sign in to see all of them.
Poliomyelitis (48) · Diphtheria (19) · Tetanus (19) · Whooping Cough (11) · Haemophilus Infections (8) · Hepatitis B (5) · Myelitis, Transverse (2) · Autoimmune Diseases of the Nervous System (1) · Cerebellar Diseases (1) · Demyelinating Autoimmune Diseases, CNS (1) · HIV Seropositivity (1) · HTLV-I Infections (1) · HTLV-II Infections (1) · Leukemia-Lymphoma, Adult T-Cell (1) · Malnutrition (1)
Central Nervous System Diseases (51) · Central Nervous System Infections (51) · Infections (51) · Nervous System Diseases (51) · Neuroinflammatory Diseases (51) · Spinal Cord Diseases (51) · RNA Virus Infections (49) · Virus Diseases (49) · Enterovirus Infections (48) · Neuromuscular Diseases (48) · Picornaviridae Infections (48) · Actinomycetales Infections (19) · Bacterial Infections (19) · Bacterial Infections and Mycoses (19)
Tetanus Toxoid (5) · Poliovirus Vaccine, Inactivated (4) · Aging (3) · Pentavac (3) · Diphtheria-Tetanus-acellular Pertussis Vaccines (2) · Poliovirus Vaccine, Oral (2) · RIX4414 vaccine (2) · diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (2) · Blood Specimen Collection (1) · Hexavac (1) · HibTITER protein, Haemophilus influenzae (1) · Interferon beta-1a (1) · Measles-Mumps-Rubella Vaccine (1) · Mitoxantrone (1) · PEDIARIX (1)
GlaxoSmithKline (10) · Sanofi Pasteur, a Sanofi Company (8) · Centers for Disease Control and Prevention (6) · Fidec Corporation (4) · Sanofi (4) · Sinovac Biotech Co., Ltd (3) · Aga Khan University (2) · Centers for Disease Control and Prevention, China (2) · Institute of Medical Biology, Chinese Academy of Medical Sciences (2) · Zhejiang Provincial Center for Disease Control and Prevention (2) · AJ Vaccines A/S (1) · Beth Israel Deaconess Medical Center (1) · London School of Hygiene and Tropical Medicine (1) · MP Biomedicals, LLC (1) · Norwegian Institute of Public Health (1)
China (13) · Bangladesh (7) · Canada (4) · United States (4) · Finland (3) · Germany (3) · Italy (3) · Australia (2) · Czechia (2) · France (2) · Norway (2) · Pakistan (2) · Panama (2) · Russia (2) · Spain (2)
Ali F Saleem, MBBS, MCR, FCPS (1) · Ali F Saleem, MBBS,FCPS,MSc (1) · Anita K.M Zaidi, MBBS, SM (1) · Bianca Weinstock-Guttman, M.D. (1) · Concepcion Estivariz, MD (1) · Ed Clarke, MD (1) · Edwin J Asturias, MD (1) · Farheen Quadri, MBBS, MSCR (1) · Gagandeep Kang, MD, PhD (1) · Harish Verma, DCH (1) · Khalequ Zaman, PhD (1) · Laxman P Shrestha, MD (1)
PMID 33487470, PMID 16831964, PMID 20448468, PMID 20616762, PMID 23077849, PMID 25882172, PMID 26407255, PMID 27212429, PMID 27364568, PMID 28444156, PMID 28455172, PMID 29477307, PMID 29571817, PMID 31104832, PMID 31776027, PMID 32442523, PMID 32621741, PMID 33612341, PMID 35575974, PMID 35961362, PMID 36064670, PMID 37283972, PMID 37652822, PMID 37774729, PMID 38388236, PMID 38400200, PMID 39088987, PMID 39146859, PMID 41295459, PMID 42610930
2014 (2), 2015 (1)